NLS Acquisition

The companies have entered into a definitive purchase agreement under which Novo Nordisk has acquired Prothena’s clinical stage antibody PRX004 and broader ATTR amyloidosis programme. PRX004 is a phase 2 ready anti-amyloid immunotherapy designed to deplete the amyloid deposits that are associated with the disease pathology of ATTR amyloidosis. ATTR amyloidosis is a rare, progressive […]

Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output, the company states in a press release. “The demand for buffers […]

The company has entered into an agreement with the shareholders of Discover Echo to acquire all outstanding shares to a purchase price of USD 110 million. Approximately eleven percent of the purchase price will be paid in newly issued shares of series B in CELLINK and the remaining part will be paid cash. Discover Echo […]

BCB Medical, the Finnish company focused on advanced software systems for gathering and analyzing clinical data, has acquired its Swedish partner in health data, Health Solutions. The acquisition gives BCB Medical opportunities for growing its business further outside Finland. “This is an important step for us towards internationalization,” says Petteri Viljanen, the CEO of BCB […]

Gilde Healthcare, a specialized healthcare investor, and KLIFO A/S, a drug development consultancy, have announce that Gilde’s Private Equity fund has acquired a majority stake in KLIFO. Gilde Healthcare aims to support KLIFO’s growth in the dynamically developing pharma outsourcing sector, the companies state in a press release. Alejandra Mørk will continue as CEO of […]

Valo Therapeutics has announced the acquisition of intellectual property rights for the ‘PeptiBAC’ technology from the University of Helsinki, Finland. “We have a strong and enduring innovation partnership with the University of Helsinki, based on our PeptiCRAd and PeptiENV technologies. Just like our PeptiVAX technology, which is rapidly adaptable to the emergence of new strains […]